- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Obamacare Will Cost 20% Less than Initial Projections, CBO Says
A new report by the Congressional Budget Office finds that, if left untouched, the Affordable Care Act is poised to become even more so.
The fate of President Obama's signature healthcare law may turn on a forthcoming ruling by the US Supreme Court, but a new report by the Congressional Budget Office (CBO) finds that, if left untouched, the Affordable Care Act is poised to become even more so.
Obamacare, as it is commonly known, will cost 20% less than previously projected over the next decade, the CBO said Monday. The reason for the revised estimate is a result of a decline of healthcare inflation, the Los Angeles Times reported. In addition, the number of uninsured Americans has fallen by 12 million, the CBO estimates, and an additional 12 million are expected to gain insurance by the end of 2016.
Read more at Bloomberg: http://bloom.bg/1BuDLnO
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More
